RWDD2A

Across TCGA pan-cancer cohorts, RWDD2A mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RWDD2A’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RWDD2A mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types RWDD2A is over-expressed in tumor, although a few such as LUAD and PDAC show the opposite, repressed pattern.

LUAD, CCRCC, and PDAC are the cancer types where RWDD2A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RWDD2A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	−0.189	.002	4	view →
CCRCC	All	All	+0.294	.018	2	view →
PDAC	All	All	−0.503	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RWDD2A–LUAD

Open the LUAD breakdown →